This research service presents a marketed and pipeline analysis of the U.S.
type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact
Sheet, 25.8 million children and adults (or 8.3 percent of the population) in
the United States suffer from diabetes. Type 2 diabetes mellitus is the most
common form of diabetes; approximately 90 to 95 percent of diabetes patients
suffer from type 2 diabetes mellitus. The purpose of this study is to
highlight the current market landscape, and provide a competitive analysis of
all marketed and pipeline drugs in development for type 2 diabetes mellitus.
Dashboard slides are provided for all marketed and Phase 3 drugs in
development for type 2 diabetes mellitus.